Yayın:
Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTurhal, N. S.
dc.contributor.authorAhmet Bilgehan Şahin
dc.contributor.authorİsmail Ertürk
dc.contributor.authorMustafa Korkmaz
dc.contributor.authorDi̇lek Erdem
dc.contributor.authorUmut Cakıroglu
dc.contributor.authorMustafa Karaca
dc.contributor.authorAhmet Dirican
dc.contributor.authorÖmer Fatih Ölmez
dc.contributor.authorSabin Göktaş Aydın
dc.contributor.authorAli Gökyer
dc.contributor.authorAhmet Küçükarda
dc.contributor.authorAhmet Gülmez
dc.contributor.authorPerran Fulden Yumuk
dc.contributor.authorNazım Can Demircan
dc.contributor.authorAbdilkerim Oyman
dc.contributor.authorTeoman Şakalar
dc.contributor.authorFatih Karataş
dc.contributor.authorHacer Demir
dc.contributor.authorAyşe İrem Yasin
dc.contributor.authorAdem Deligönül
dc.contributor.authorBahar Dakiki
dc.contributor.authorMehmet Refik Goktug
dc.contributor.authorOkan Avcı
dc.contributor.authorSeher Yıldız Tacar
dc.contributor.authorN. S. Turhal
dc.contributor.authorGülhan Ipek Deniz
dc.contributor.authorTurgut Kaçan
dc.contributor.authorErdem Çubukçu
dc.contributor.authorTürkkan Evrensel
dc.contributor.orcid0000-0001-7537-1699
dc.contributor.orcid0000-0002-7846-0870
dc.contributor.orcid0000-0003-3204-4430
dc.contributor.orcid0000-0003-0926-6748
dc.contributor.orcid0000-0001-6495-6712
dc.contributor.orcid0000-0002-8204-6154
dc.contributor.orcid0000-0001-6992-9289
dc.contributor.orcid0000-0001-7934-7039
dc.contributor.orcid0000-0002-0077-6971
dc.contributor.orcid0000-0002-1653-6155
dc.contributor.orcid0000-0001-7399-2360
dc.contributor.orcid0000-0002-3353-344X
dc.contributor.orcid0000-0001-8650-299X
dc.contributor.orcid0000-0001-6630-5278
dc.contributor.orcid0000-0002-2291-7544
dc.contributor.orcid0000-0003-2749-9414
dc.contributor.orcid0000-0003-4022-7923
dc.contributor.orcid0000-0003-1235-9363
dc.contributor.orcid0000-0002-1528-8065
dc.contributor.orcid0000-0002-3669-6391
dc.contributor.orcid0000-0001-9255-2475
dc.contributor.orcid0000-0003-3773-6620
dc.contributor.orcid0000-0001-7581-0962
dc.contributor.orcid0000-0002-1013-5676
dc.contributor.orcid0000-0002-2067-1560
dc.contributor.orcid0000-0002-0070-0889
dc.contributor.orcid0000-0002-9732-5340
dc.date.accessioned2025-11-18T22:54:32Z
dc.date.issued2024-09-04
dc.identifier.doihttps://doi.org/10.3390/curroncol31090384
dc.identifier.endpage5205
dc.identifier.issn1198-0052
dc.identifier.issue9
dc.identifier.openalexW4402242437
dc.identifier.startpage5195
dc.identifier.urihttps://hdl.handle.net/11421/16843
dc.identifier.urihttp://doi.org/10.3390/curroncol31090384
dc.identifier.volume31
dc.language.isoen
dc.relation.ispartofCurrent Oncology
dc.rightsopenAccess
dc.subjectMedicine
dc.subjectNivolumab
dc.subjectRenal cell carcinoma
dc.subjectNephrectomy
dc.subjectOncology
dc.subjectInternal medicine
dc.subjectUrology
dc.subjectCancer research
dc.subjectKidney
dc.subjectImmunotherapy
dc.subjectCancer
dc.subject.sdg3
dc.titleCan Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5064011743

Dosyalar

Koleksiyonlar

Publications